Autolus Therapeutics Ltd reported $366.78M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
AstraZeneca USD 31.45B 3.48B Sep/2026
Autolus Therapeutics Ltd USD 366.78M 30.69M Sep/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Novartis USD 28.75B 1.4B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Silence Therapeutics USD 118.66M 14.97M Dec/2025